Last reviewed · How we verify
Self-administered prescription — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Self-administered prescription (Self-administered prescription) — McGill University Health Centre/Research Institute of the McGill University Health Centre.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Self-administered prescription TARGET | Self-administered prescription | McGill University Health Centre/Research Institute of the McGill University Health Centre | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Self-administered prescription CI watch — RSS
- Self-administered prescription CI watch — Atom
- Self-administered prescription CI watch — JSON
- Self-administered prescription alone — RSS
Cite this brief
Drug Landscape (2026). Self-administered prescription — Competitive Intelligence Brief. https://druglandscape.com/ci/self-administered-prescription. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab